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ABSTRACT
Preliminary published data depicts a much greater prevalence of malewith laboratory-confirmed 
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) referred for intensive care unit 
admission and severe sequelae in several countries. In this context, males seem to not only be more 
susceptible to the infection compared to female subjects, at least in western countries, but their case 
fatality rate attributable to SARS-CoV-2 infection is also highest. Therefore, we may speculate that 
the different hormonal milieu could have a more profound pathophysiological role in association with 
SARS-CoV-2, with endogenous testosterone leaving men more prone to develop more serious 
complications related to the SARS-CoV-2 infection. Another option is that SARS-CoV-2 infection 
per se causes an acute stage of male hypogonadism, the depletion of androgenic action triggering 
serious or an even fatal course of the disease. Therefore, we stongly advocate the development of a 
prospective multidimensional andrological translational research project in men, which we called the 
PROTEGGIMI study. In this Opinion Article we will not only highlight novel research activity in this 
area but also invite other researchers and learned scientific societies to join us in our efforts to 
understand an important and very newly discovered gap in knowledge, which may have serious 
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INTRODUCTION
The new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), previously provisionally 
named 2019 novel coronavirus or 2019-nCoV disease (COVID-19), has been associated with acute 
respiratory distress syndrome1 and infected patients have a relatively high risk of death. Recently it 
has been also hypothesized that SARS-CoV-2-induced infection may lead to a more complex clinical 
picture termed microCLOTS syndrome (i.e., microvascular SARS-CoV-2-associated lung vessels 
obstructive thromboinflammatory syndrome)2. Further data has suggested that the human lung, liver, 
gastrointestinal tract, cardiovascular and the urinary systems are potential targets of SARS-CoV-2 
infection3. In this context, the first retrospective case series published on a large cohort of consecutive 
patients with laboratory-confirmed SARS-CoV-2 referred for intensive care unit (ICU) admission to 
the coordination center of the SARS-CoV-2 in the ICU Network of the Lombardy region in Italy 
clearly depicted a dramatic snapshot: of 1591 patients, extraordinarily 1304 (82%) were males at the 
final follow-up at March 25, 20204. Similar trends have also been reported in other countries5.
ANDROLOGICAL RELEVANCE
Not only has this terrible pandemic infection had a devastating effect on the everyday life of the 
population globally, it has also further highlighted a prevailing gender gap in health; indeed, it seems 
that male individuals are not only more susceptible to the infection, at least in the western countries, 
but their death rate attributable to SARS-CoV-2 is also highest6, thus confirming the pre-exisiting 
gender inequality in life expectancy7. The reasons for this gender disparity in disease severity are 
unclear, but may be related to host factors. If these observations are extrapolated to the real-life 
setting of both our daily clinical practice and that of andrological translational research to which we 
have dedicated ourselves over the past 20 years and more, this may mean that the hormonal milieu 
could have a much greater pathophysiological role in association with SARS-CoV-28,9. 
In other words, testosterone - a hormone in many ways consubstantial with the existence of males - is 
not only important for their quality of life10, but may lead to men being more susceptible to the 
development of other serious complications related to infection of SARS-CoV-2 compared to women. 
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depletion of androgenic action triggering serious or an even fatal course of the disease. Recent 
preliminary data would also support this hypothesis11. Indeed, comparing sex-related hormones of a 
cohort of men of reproductive age with SARS-CoV-2 infection and those of age-matched healthy 
men, Ma et al. reported the first direct evidence of a potential alteration of the androgenic hormonal 
milieu, as a consequence of the complex influence of the medical condition toward sex hormones; this 
being true at least in reproductive-aged SARS-CoV-2-infected males11.
However, we can only speculate for the time being, as a potential pathophysiological interaction of 
sex hormones (and, mostly, testosterone), SARS-CoV-28 and its receptor angiotensin-converting 
enzyme 2 (ACE2) – the “entrance” into target host cells12,13 – has yet only been minimally 
investigated8,14.
On the whole, coronavirus entry into host cells is mediated by the trans-membrane spike (S) 
glycoprotein that forms homotrimers protruding from the viral surface13. S comprises two functional 
subunits which are responsible for binding to the host cell receptor (S1 subunit) and fusion of the viral 
and cellular membranes (S2 subunit). S1 and S2 subunits interact each other within a complex system 
that leads to an extensive and irreversible set of conformational changes. As a result, coronavirus 
entry into susceptible cells is a highly complex process that eventually requires the concerted action 
of receptor-binding and the proteolytic processing of the S protein to promote virus-cell fusion. In 
addiction, different coronaviruses have been demonstrated to use distinct domains within the S1 
subunit to recognize a varity of attachments to entry receptors; SARS-CoV viruses interact directly 
with ACE2 via their S domain B (SB) to enter target cells13. 
Recently, ACE2 expression levels have been demonstrated to be higher in males than in females, at 
least in the lungs15. Furthermore, a more detailed analysis of the expression pattern of ACE2 in adult 
human testes, utilising uniform manifold approximation and projection (UMAP) and marker gene 
analysis, also indicates that ACE2 is predominantly enriched in spermatogonia, Leydig and Sertoli 
cells16; therefore, it has been speculated that the human testis may be a further potential route of 
SARS-CoV-2 infection. Conversely, early spermatocytes, late spermatocytes, spermatids and somatic 
cells express very low levels of ACE216. Of relevance, the enrichment of ACE2 in Leydig and Sertoli 
cells demonstrated a 3-fold higher percentage compared to ACE2-expressing cells among type II 
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testicular cells – and in contrast, low levels of observed expression ACE2 in ovarian tissue17,18 – 
supports the concept of the testes as specific repositories, supporting the hypothesis that male subjects 
have even delayed viral clearance of SARS-CoV-2 compared to their female counterparts18.
As a consequence, ACE2 expression in human testes – which has been also found at the protein 
levels18 – suggests that SARS-CoV-2 could eventually infect the male testis, with a consequential risk 
in terms of male reproductive dysfunction, because of a disruption of spermatogenesis if 
spermatogonia were infected by the virus16.
Furthermore, SARS-CoV-2 was found to utilise transmembrane serine protease 2 (TMPRSS2) for 
viral S protein priming19. TMPRSS2 expression has been found to be concentrated in spermatogonia 
and spermatids16. Interstingly: TMPRSS2 is an androgen-regulated cell surface protease, which had 
been previously found to be predominantly expressed in prostate epithelium20. Moreover, the 
connection is even more definitive since i) the development of the prostate gland is finely regulated 
by androgens which modulate its growth and function; and, ii) androgens exert a major role in 
prostate cancer development and progression and, among others, one of the hypotheses relies on a 
chromosomal rearrangement of the androgen regulated gene TMPRSS2 with the ETS transcription 
factor ERG20,21. Thus, to substantiate this hypothesis one must experimentally confirm it. 
ACTION IS NEEDED 
Whereas we are still at the stage where the whole world focuses on limiting the spread of the SARS-
CoV-2 and saving lives of severely ill SARS-CoV-2 patients, as scientists we also have responsibility 
for elucidating the underlying cause of the wide gender difference in sensitivity to the harmful effects 
of SARS-CoV-2 and to explore the possible adverse long-term effects on male reproductive function. 
Therefore, these questions have facilitated the development of a prospective multidimensional 
andrological translational research project, which we have called PROTEGGIMI (PROgetto 
TEstosterone e fraGIlità negli uoMIni) study.
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1) develop an international (European) data Registry providing information on demographic, 
epidemiological and pathological/functional outcomes of laboratory-confirmed SARS-CoV-2 in 
males and of the same-ethnicity and age-matched healthy controls, taking into consideration that case 
fatality rate – and, their severe sequelae – may vary geographically, between age groups and 
temporarily; 
2) assess both cross-sectionally and with a case-control analysis the circulating hormonal milieu in 
patients (according to age; ethnicity; comorbidities; BMI; symptoms; therapeutic approaches, and 
outcomes), and in age-matched healthy controls; 
3) assess the genomic profile of specific subsets of confirmed SARS-CoV-2 males at higher 
susceptibility for severe sequaele and greater risk of death, in association with a specific androgenic 
profiles; 
4) develop in vitro culture systems to investigate the impact of testosterone on different tissues, 
including human ACE2 in the testis and the reproductive tract16, including epithelial and endothelial 
lung cells22; 
5) develop an animal model which may recapitulate the differences in terms of overall outcomes 
according to sex (females vs. males) and the associated hormonal milieu23. 
Moreover, it is clear that to elucidate the underlying pathophysiological mechanisms of SARS-CoV-2 
action in the acute phase, there is also the need to evaluate long-term effects of the virus and in this 
respect we have agreed to develop a longitudinal study in terms of androgenic profile and monitoring 
possible SARS-CoV-2 infection-related changes in terms of male accessory glands physiology as well 
as semen quality as biological markers of overall male health and, more specifically, male 
reproductive potential. Indeed, very recent preliminary case-control findings have demonstrated that 
the process of spermatogenesis could potentially be damaged after SARS-CoV-2 recovery, especially 
in men of reproductive age11. 
This can and, we believe, should be our commitment to translational research as andrologists in this 
dramatic era of SARS-CoV-2.
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In this Opinion Article we have highlighted the urgent need for novel research activities in this area 
and invite collaboration among Scientific Societies involved in the field of andrology, including other 
scientific researchers to join us in our efforts bridge a very newly-discovered gap in knowledge, 
which may have serious short- and long-term implications for the lives of millions of men.
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